CLINICAL AND THERAPEUTIC ADVANCES IN THE MANAGEMENT OF UROLOGICAL DISORDERS AFFECTING RENAL FUNCTION

Abstract

Urological disorders are a significant cause of renal dysfunction and contribute substantially to the global burden of chronic kidney disease (CKD). Conditions such as benign prostatic hyperplasia, urinary tract obstruction, urolithiasis, recurrent urinary tract infections, neurogenic bladder, congenital anomalies, and urological malignancies can impair renal function through complex mechanisms involving obstruction, inflammation, oxidative stress, vascular dysfunction, and progressive fibrosis. This narrative review synthesizes recent evidence on the pathophysiological links between urological disorders and renal impairment while evaluating advances in diagnostic and therapeutic strategies aimed at preserving kidney function. Contemporary diagnostic approaches, including sensitive renal biomarkers, multimodal imaging, endoscopic evaluation, and artificial intelligence-assisted technologies, have improved the early identification of renal injury and enhanced clinical decision-making. Therapeutic innovations, particularly minimally invasive endourological procedures, robotic and image-guided surgery, precision medicine, regenerative therapies, and targeted drug delivery systems, have expanded treatment options while reducing procedural morbidity. The review also highlights the importance of multidisciplinary management involving urologists, nephrologists, radiologists, and primary care teams in preventing CKD progression through coordinated monitoring, individualized treatment, and long-term renal protection. Finally, emerging technologies, including digital health, predictive analytics, and genomics, are discussed alongside current clinical challenges and future research priorities. Integrating these advances into evidence-based clinical practice has the potential to improve renal preservation, optimize patient outcomes, and reduce the long-term burden of urological diseases affecting kidney function.